Subcategories:

Sort by:

select Language:



Medicines Catalog August 2018

Global Drug Facility, Eds.: World Health Organization WHO, Stop TB, (2018)


The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
http://stoptb.org/assets/documents/gdf/Medicines_C...


UPDATING NATIONAL ESSENTIAL MEDICINE LISTS: A STEP-BY-STEP ADVOCACY GUIDE

Eds.: Management Sciences for Health (MSH), (2016)


This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, timeline, and process may vary from country to country, this guide presents the broad steps involved in revising an EML for any health commodity. Additional resources and a glossary are included to provide supplemental information and to clarify key terms.
https://www.msh.org/resources/updating-national-es...


IMPROVING MEDICINES ACCESS AND USE FOR CHILD HEALTH: A GUIDE TO DEVELOPING INTERVENTIONS

Ross-Degnan, D., Vialle-Valentin, C., and Briggs, J. , Eds.: USAID, SIAPS (Systems for Improved Access to Pharmaceuticals and Services), (2015)


Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for both health policy makers and health system managers and presents a structured approach to the steps introduced in the framework in the context of child health.
https://www.msh.org/sites/msh.org/files/ch_interve...


Guidelines for the production, control and regulation of snake antivenom immunoglobulins

[World Health Organization (WHO)], (2017)


Replacement of Annex 2 of WHO Technical Report Series, No. 964

http://www.who.int/bloodproducts/AntivenomGLrevWHO...


World Health Organization Model List of Essential In Vitro Diagnostics First edition (2018)

World Health Organization (WHO), (2018)


The World Health Organization (WHO) published the first edition of the Model List of Essential In Vitro Diagnostics (EDL) in May 2018, in recognition that IVDs are an essential component to advance universal health coverage, address health emergencies, and promote healthier populations, which are the three strategic priorities of the WHO Thirteenth General Programme of Work (2019–2023)(GPW). The EDL is also intended to complement the WHO Model List of Essential Medicines (EML) and inhance its impact.
http://www.who.int/medical_devices/diagnostics/WHO...


MSF Essential Drugs - Practical Guidelines. Arabic Version

Medécins sans Frontières, (2016)


This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug management. We have tried to provide simple, practical solutions to the questions and problems faced by field medical staff, using the accumulated field experience of Médecins Sans Frontières, the recommendations of reference organizations such as the World Health Organization (WHO) and specialized documentation in each field.
http://www.refbooks.msf.org/msf_docs/ar/ed_ar.pdf


Selection and Use of Essential Medicines

World Health Organization WHO, (2017)


The Expert Committee considered 92 applications, including proposals to add 41 new medicines and extend the indications for six existing listed medicines, five applications to delete medicines from the lists, and a comprehensive review of the antibacterials listed in sections 6.2.1 and 6.2.2 and their use in the treatment of 21 common, priority infectious syndromes, five paediatric infectious diseases and three sexually transmitted infections. In accordance with approved procedures, the Expert Committee evaluated the scientific evidence for the comparative effectiveness, safety and cost–effectiveness of the medicines.
http://apps.who.int/iris/bitstream/10665/259481/1/...


MSF Essential Drugs - Practical Guidelines

Sophie Pilon, Véronique Grouzard, Eds.: Médecins sans Frontières, (2017)


This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug management. We have tried to provide simple, practical solutions to the questions and problems faced by field medical staff, using the accumulated field experience of Médecins Sans Frontières, the recommendations of reference organizations such as the World Health Organization (WHO) and specialized documentation in each field. Also available in French, Spanish and Arabic
https://medicalguidelines.msf.org/viewport/MG/en/g...


WHO Model List of Essential Medicines 20th List (March 2017)

World Health Organization WHO, (2017)


The 20th Essential Medicines List, published on 6 June 2017, marks the 40th anniversary of this flagship WHO tool to expand access to medicines. The updated list adds 30 medicines for adults and 25 for children, and specifies new uses for 9 already-listed products, bringing the total to 433 drugs deemed essential for addressing the most important public health needs globally. The 20th List also provides new advice on which antibiotics to use for common infections and which to preserve for the most serious syndromes, based on a thorough review of all essential antibiotics. The aim is to optimise antibiotic use and reduce antibiotic resistance without restricting access. Other important additions include medicines for HIV, hepatitis C, tuberculosis and cancer
http://www.who.int/medicines/publications/essentia...


42 hits